Purvesh Khatri has followed a winding path to medicine -- one that started with a hate for biology and a career in engineering.
Researchers at Stanford Medicine have investigated the mechanism of pulmonary fibrosis caused by long COVID.
As FDA weighs a ban on menthol in cigarettes, study shows how the tobacco industry targeted products to women, teens and Black people.
Researchers are making connections between the role of mucus and human health -- both in the brain and the lungs.
Early in the pandemic, with few clues about how to treat critically-ill COVID-19 patients, Stanford’s ICU team developed and shared expertise to save lives.
The COVID-19 pandemic gives new relevance to a synthetic substance developed by Stanford researchers that could help respiratory patients breathe easier.
Some viruses help drug-resistant bacteria grow in the lungs of cystic fibrosis patients, new Stanford research shows.
By scouting for a particular immune cell in the blood, scientists can tell which patients with a lung-scarring disease are at higher risk for death.
Exposure to 'third-hand smoke' — that is, the chemicals left behind on household surfaces after smoke has dissipated — increases the severity of asthma symptoms in mice. Stanford researchers are working to learn how this happens, and whether it might be possible to protect people with asthma from this exposure.
What makes breathing possible is a thin coating of a soaplike film, or surfactant, that lowers the tension of the lung’s inner surface. Premature babies and adults with lung injuries are short on surfactant, and replacing it has been prohibitively pricey. That may be about to change.
This Stars of Stanford Medicine Q&A features Kristina Kudelko, who specializes in pulmonary hypertension. She also runs, loves music and spending time with her family.
When I mention to people that I had a double lung transplant, they usually react in one of two ways. They're likely to say, "Wow, …